A citation-based method for searching scientific literature

Stephanie Keeling, Walter P Maksymowych. Expert Rev Clin Immunol 2021
Times Cited: 6







List of co-cited articles
24 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study.
Atul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang,[...]. Ann Rheum Dis 2021
37
50

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Désirée van der Heijde, In-Ho Song, Aileen L Pangan, Atul Deodhar, Filip van den Bosch, Walter P Maksymowych, Tae-Hwan Kim, Mitsumasa Kishimoto, Andrea Everding, Yunxia Sui,[...]. Lancet 2019
111
50

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Maarten de Wit,[...]. Ann Rheum Dis 2020
50

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy M Fleischmann, Klaus Geissler, Iain McInnes, Janet E Pope, Désirée van der Heijde, Michaela Stoffer-Marx,[...]. Ann Rheum Dis 2021
75
50

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
Désirée van der Heijde, Sofia Ramiro, Robert Landewé, Xenofon Baraliakos, Filip Van den Bosch, Alexandre Sepriano, Andrea Regel, Adrian Ciurea, Hanne Dagfinrud, Maxime Dougados,[...]. Ann Rheum Dis 2017
821
33

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
Désirée van der Heijde, Xenofon Baraliakos, Lianne S Gensler, Walter P Maksymowych, Vira Tseluyko, Oleg Nadashkevich, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Robin Besuyen,[...]. Lancet 2018
132
33

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study.
Désirée van der Heijde, Atul Deodhar, James C Wei, Edit Drescher, Dona Fleishaker, Thijs Hendrikx, David Li, Sujatha Menon, Keith S Kanik. Ann Rheum Dis 2017
194
33

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
M Rudwaleit, D van der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, J Braun, C T Chou, E Collantes-Estevez, M Dougados,[...]. Ann Rheum Dis 2009
33


JAK1 inhibition and inflammatory bowel disease.
Clare Harris, J R Fraser Cummings. Rheumatology (Oxford) 2021
9
33

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.
Daniella M Schwartz, Yuka Kanno, Alejandro Villarino, Michael Ward, Massimo Gadina, John J O'Shea. Nat Rev Drug Discov 2017
413
33

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.
Paqui G Traves, Bernard Murray, Federico Campigotto, René Galien, Amy Meng, Julie A Di Paolo. Ann Rheum Dis 2021
38
33

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J Richardson, Vanessa Monteil, Volker M Lauschke, Ali Mirazimi, Sonia Youhanna,[...]. EMBO Mol Med 2020
152
33


Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
Iain B McInnes, Jaclyn K Anderson, Marina Magrey, Joseph F Merola, Yi Liu, Mitsumasa Kishimoto, Slawomir Jeka, Cesar Pacheco-Tena, Xin Wang, Liang Chen,[...]. N Engl J Med 2021
51
33

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Andre C Kalil, Thomas F Patterson, Aneesh K Mehta, Kay M Tomashek, Cameron R Wolfe, Varduhi Ghazaryan, Vincent C Marconi, Guillermo M Ruiz-Palacios, Lanny Hsieh, Susan Kline,[...]. N Engl J Med 2021
856
33

Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
Mark C Genovese, Roy Fleischmann, Bernard Combe, Stephen Hall, Andrea Rubbert-Roth, Ying Zhang, Yijie Zhou, Mohamed-Eslam F Mohamed, Sebastian Meerwein, Aileen L Pangan. Lancet 2018
204
33

The role of antirheumatics in patients with COVID-19.
Christoffer B Nissen, Savino Sciascia, Danieli de Andrade, Tatsuya Atsumi, Ian N Bruce, Randy Q Cron, Oliver Hendricks, Dario Roccatello, Ksenija Stach, Mattia Trunfio,[...]. Lancet Rheumatol 2021
20
33

JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis.
Francesco Campanaro, Alberto Batticciotto, Andrea Zaffaroni, Antonella Cappelli, Marco Paolo Donadini, Alessandro Squizzato. Autoimmun Rev 2021
10
33

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach.
Yoshiya Tanaka, Yiming Luo, John J O'Shea, Shingo Nakayamada. Nat Rev Rheumatol 2022
28
33

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Steven R Ytterberg, Deepak L Bhatt, Ted R Mikuls, Gary G Koch, Roy Fleischmann, Jose L Rivas, Rebecca Germino, Sujatha Menon, Yanhui Sun, Cunshan Wang,[...]. N Engl J Med 2022
118
33

Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Mark Yates, Amanda Mootoo, Maryam Adas, Katie Bechman, Sanketh Rampes, Vishit Patel, Sumera Qureshi, Andrew P Cope, Sam Norton, James B Galloway. Arthritis Rheumatol 2021
47
33

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Liana Fraenkel, Joan M Bathon, Bryant R England, E William St Clair, Thurayya Arayssi, Kristine Carandang, Kevin D Deane, Mark Genovese, Kent Kwas Huston, Gail Kerr,[...]. Arthritis Rheumatol 2021
107
33

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
295
33

European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.
Stephan Miehlke, Danila Guagnozzi, Yamile Zabana, Gian E Tontini, Anne-Marie Kanstrup Fiehn, Signe Wildt, Johan Bohr, Ole Bonderup, Gerd Bouma, Mauro D'Amato,[...]. United European Gastroenterol J 2021
41
16

Golimumab for the treatment of ulcerative colitis.
Mathurin Flamant, Stephane Paul, Xavier Roblin. Expert Opin Biol Ther 2017
20
16

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.
Janneke J de Winter, Leonieke J van Mens, Désirée van der Heijde, Robert Landewé, Dominique L Baeten. Arthritis Res Ther 2016
123
16

IBD considerations in spondyloarthritis.
Caroline Di Jiang, Tim Raine. Ther Adv Musculoskelet Dis 2020
7
16

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.
Dennis McGonagle, Abdulla Watad, Kassem Sharif, Charlie Bridgewood. Front Immunol 2021
10
16

Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Ignazio Olivieri, Fabrizio Cantini, Fabiana Castiglione, Carla Felice, Paolo Gionchetti, Ambrogio Orlando, Carlo Salvarani, Raffaele Scarpa, Maurizio Vecchi, Alessandro Armuzzi. Autoimmun Rev 2014
61
16

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
Alexander C von Roon, Leonidas Karamountzos, Sanjay Purkayastha, George E Reese, Ara W Darzi, Julian P Teare, Paraskevas Paraskeva, Paris P Tekkis. Am J Gastroenterol 2007
275
16

Psoriatic Arthritis, Psoriatic Disease, or Psoriatic Syndrome?
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta. J Rheumatol 2019
18
16


Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
893
16

Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.
H Cypers, G Varkas, S Beeckman, K Debusschere, T Vogl, J Roth, M B Drennan, M Lavric, D Foell, C A Cuvelier,[...]. Ann Rheum Dis 2016
66
16

Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
Eva Klingberg, Hans Carlsten, Elisabet Hilme, Martin Hedberg, Helena Forsblad-d'Elia. Scand J Gastroenterol 2012
62
16

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation.
Francesco Ciccia, Michele Bombardieri, Aroldo Rizzo, Alfonso Principato, Anna R Giardina, Francesca Raiata, Sergio Peralta, Angelo Ferrante, Sandro Drago, Mario Cottone,[...]. Rheumatology (Oxford) 2010
38
16

The spectrum of perianal Crohn's disease in a population-based cohort.
Tim W Eglinton, Murray L Barclay, Richard B Gearry, Frank A Frizelle. Dis Colon Rectum 2012
122
16

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.
Taina Sipponen, Clas-Göran A F Björkesten, Martti Färkkilä, Hannu Nuutinen, Erkki Savilahti, Kaija-Leena Kolho. Scand J Gastroenterol 2010
118
16

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.
M Dougados, S van der Linden, R Juhlin, B Huitfeldt, B Amor, A Calin, A Cats, B Dijkmans, I Olivieri, G Pasero. Arthritis Rheum 1991
16

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter D R Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski,[...]. Gut 2012
992
16

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.
Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen, Lai-Shan Tam, Carlo Salvarani, Tae-Hwan Kim, Alan Solinger, Yakov Datsenko,[...]. Ann Rheum Dis 2018
183
16

Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Manuel Otero Santiago, Aurelio Lorenzo Gonzalez, Carmen Alonso de la Peña, Alfonso J Benitez Estevez, Juan Enrique Dominguez-Muñoz. J Clin Gastroenterol 2016
52
16


Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis.
R D Østgård, B W Deleuran, M Y Dam, I T Hansen, A G Jurik, H Glerup. Scand J Rheumatol 2018
21
16

Peripheral spondyloarthritis: a neglected entity-state of the art.
Philippe Carron, Ann-Sophie De Craemer, Filip Van den Bosch. RMD Open 2020
17
16

Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
Marine Fauny, Ferdinando D'Amico, Stefanos Bonovas, Patrick Netter, Silvio Danese, Damien Loeuille, Laurent Peyrin-Biroulet. J Crohns Colitis 2020
14
16


Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
922
16

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Philip J Mease, Désirée van der Heijde, Christopher T Ritchlin, Masato Okada, Raquel S Cuchacovich, Catherine L Shuler, Chen-Yen Lin, Daniel K Braun, Chin H Lee, Dafna D Gladman. Ann Rheum Dis 2017
313
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.